Janiczek Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$258K Sell
5,315
-1,308
-20% -$63.1K 0.05% 149
2024
Q1
$322K Buy
6,623
+718
+12% +$35.1K 0.07% 121
2023
Q4
$294K Buy
5,905
+1,161
+24% +$56.8K 0.07% 114
2023
Q3
$254K Buy
4,744
+478
+11% +$25.5K 0.07% 121
2023
Q2
$230K Buy
4,266
+54
+1% +$2.91K 0.06% 116
2023
Q1
$237K Sell
4,212
-92
-2% -$4.47K 0.07% 106
2022
Q4
$212K Buy
4,304
+84
+2% +$3.69K 0.06% 116
2022
Q3
$165K Buy
4,220
+2,838
+205% +$126K 0.05% 127
2022
Q2
$69K Sell
1,382
-1,258
-48% -$66.8K 0.02% 258
2022
Q1
$136K Buy
2,640
+1,160
+78% +$59.9K 0.04% 167
2021
Q4
$74K Buy
1,480
+6
+0.4% +$297 0.02% 237
2021
Q3
$71K Sell
1,474
-242
-14% -$12.3K 0.03% 225
2021
Q2
$90K Buy
1,716
+1,196
+230% +$62.4K 0.03% 170
2021
Q1
$26K Sell
520
-332
-39% -$15.9K 0.01% 352
2020
Q4
$41K Buy
852
+562
+194% +$27.7K 0.02% 234
2020
Q3
$15K Buy
290
+206
+245% +$10.6K 0.01% 187
2020
Q2
$4K Buy
+84
New +$4.08K ﹤0.01% 212

Other funds holding SNY

Janiczek Wealth Management's SNY Position: Q2 2024 in Review

Janiczek Wealth Management reduced its Sanofi (SNY) stake by 20% in Q2 2024, selling an estimated $63.1K and leaving 5,315 shares worth $258K. The position accounts for 0.05% of the portfolio, ranked #149.

Janiczek Wealth Management first reported a position in SNY in Q2 2020 and has held it in 17 quarters since. The position peaked at $322K in Q1 2024. 728 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Janiczek Wealth Management held 5,315 shares of Sanofi worth $258K as of Q2 2024.
  • Janiczek Wealth Management sold 1,308 Sanofi shares in Q2 2024, an estimated $63.1K.
  • Sanofi made up 0.05% of Janiczek Wealth Management's portfolio in Q2 2024, its #149 holding.
  • Janiczek Wealth Management first reported a position in Sanofi in Q2 2020 and has held it in 17 quarters since.
  • Janiczek Wealth Management's Sanofi position peaked at $322K in Q1 2024.
  • 728 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.